These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15811960)

  • 21. Paroxysmal nocturnal hemoglobinuria: the price for a chance.
    Bessler M
    Schweiz Med Wochenschr; 1996 Nov; 126(45):1912-21. PubMed ID: 8946596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flow cytometric analysis of glycosylphosphatidyl-inositol-anchored proteins to assess paroxysmal nocturnal hemoglobinuria clone size.
    Piedras J; López-Karpovitch X
    Cytometry; 2000 Aug; 42(4):234-8. PubMed ID: 10934342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the expression of glycosylphosphatidylinositol anchored proteins on platelets from patients with paroxysmal nocturnal hemoglobinuria.
    Maciejewski JP; Young NS; Yu M; Anderson SM; Sloand EM
    Thromb Res; 1996 Sep; 83(6):433-47. PubMed ID: 8885138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD34+ cells from paroxysmal nocturnal hemoglobinuria (PNH) patients are deficient in surface expression of cellular prion protein (PrPc).
    Risitano AM; Holada K; Chen G; Simak J; Vostal JG; Young NS; Maciejewski JP
    Exp Hematol; 2003 Jan; 31(1):65-72. PubMed ID: 12543108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Application of fluorescence in situ hybridization and flow cytometry in the measurement of telomere length in Chinese patients with bone marrow failure syndrome].
    Liu B; Cui W; Han B; Wang X; Lin J; Zhao YQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Oct; 31(5):547-50. PubMed ID: 19968067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presentation clinical, haematological and immunophenotypic features of 1081 patients with GPI-deficient (paroxysmal nocturnal haemoglobinuria) cells detected by flow cytometry.
    Richards SJ; Dickinson AJ; Cullen MJ; Griffin M; Munir T; McKinley C; Mitchell LD; Newton DJ; Arnold L; Hill A; Hillmen P
    Br J Haematol; 2020 Jun; 189(5):954-966. PubMed ID: 32103498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating PIG-A mutant T lymphocytes in healthy adults and patients with bone marrow failure syndromes.
    Ware RE; Pickens CV; DeCastro CM; Howard TA
    Exp Hematol; 2001 Dec; 29(12):1403-9. PubMed ID: 11750098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance of paroxysmal nocturnal hemoglobinuria cells to the glycosylphosphatidylinositol-binding toxin aerolysin.
    Brodsky RA; Mukhina GL; Nelson KL; Lawrence TS; Jones RJ; Buckley JT
    Blood; 1999 Mar; 93(5):1749-56. PubMed ID: 10029605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis of paroxysmal nocturnal hemoglobinuria in peripheral blood and bone marrow with six-color flow cytometry.
    Yang HS; Yang M; Li X; Tugulea S; Dong H
    Biomark Med; 2013 Feb; 7(1):99-111. PubMed ID: 23387491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Origin and fate of blood cells deficient in glycosylphosphatidylinositol-anchored protein among patients with bone marrow failure.
    Sugimori C; Mochizuki K; Qi Z; Sugimori N; Ishiyama K; Kondo Y; Yamazaki H; Takami A; Okumura H; Nakao S
    Br J Haematol; 2009 Oct; 147(1):102-12. PubMed ID: 19656154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria.
    Takeda J; Miyata T; Kawagoe K; Iida Y; Endo Y; Fujita T; Takahashi M; Kitani T; Kinoshita T
    Cell; 1993 May; 73(4):703-11. PubMed ID: 8500164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral blood cells are predominantly chimeric of affected and normal cells in patients with paroxysmal nocturnal hemoglobinuria: simultaneous investigation on clonality and expression of glycophosphatidylinositol-anchored proteins.
    Ohashi H; Hotta T; Ichikawa A; Kinoshita T; Taguchi R; Kiguchi T; Ikezawa H; Saito H
    Blood; 1994 Feb; 83(3):853-9. PubMed ID: 7507738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular basis of paroxysmal nocturnal hemoglobinuria.
    Parker CJ
    Stem Cells; 1996 Jul; 14(4):396-411. PubMed ID: 8843541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic significance of measurement of the receptor for urokinase-type plasminogen activator on granulocytes and in plasma from patients with paroxysmal nocturnal hemoglobinuria.
    Gao W; Wang Z; Bai X; Li Y; Ruan C
    Int J Hematol; 2002 May; 75(4):434-9. PubMed ID: 12041678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The molecular basis of paroxysmal nocturnal hemoglobinuria.
    Rosti V
    Haematologica; 2000 Jan; 85(1):82-7. PubMed ID: 10629597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol-anchored protein-deficient clones.
    Maciejewski JP; Rivera C; Kook H; Dunn D; Young NS
    Br J Haematol; 2001 Dec; 115(4):1015-22. PubMed ID: 11843844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotypic and phenotypic implications in paroxysmal nocturnal hemoglobinuria (PNH): a preliminary investigation.
    Pakdeesuwan K; Siripanyaphinyo U; Pramoonjago P; Pattanapanyasat K; Wilairat P; Kinoshita T; Wanachiwanawin W
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 3():58-63. PubMed ID: 9640601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Spontaneous recovery from pancytopenia in a young female patient with paroxysmal nocturnal hemoglobinuria(PNH): changes in the GPI-anchor expression on peripheral blood cells].
    Inukai T; Sugita K; Goto M; Nakamura M; Tezuka T; Goi K; Iijima K; Ishihara T; Kagami K; Noji H; Shichishima T; Nakazawa S
    Rinsho Ketsueki; 2004 Mar; 45(3):238-42. PubMed ID: 15103939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential gene expression in hematopoietic progenitors from paroxysmal nocturnal hemoglobinuria patients reveals an apoptosis/immune response in 'normal' phenotype cells.
    Chen G; Zeng W; Maciejewski JP; Kcyvanfar K; Billings EM; Young NS
    Leukemia; 2005 May; 19(5):862-8. PubMed ID: 15759038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paroxysmal nocturnal hemoglobinuria: molecular pathogenesis and molecular therapeutic approaches.
    Nishimura J; Smith CA; Phillips KL; Ware RE; Rosse WF
    Hematopathol Mol Hematol; 1998; 11(3-4):119-46. PubMed ID: 9844822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.